Troy Edward Wilson Avidity Biosciences, Inc. (RNA) insider trading activity

Troy Edward Wilson is Director of Avidity Biosciences, Inc.. Currently has a direct ownership of 69,425 shares of RNA, which is worth approximately $2.33 Million. The most recent transaction as insider was on Jun 10, 2025, when has been sold 6,692 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.4K

22.53% 3M change

22.53% 12M change

Total Value Held $2.33 Million

TROY EDWARD WILSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 10 2025	BUY Grant, award, or other acquisition	-	6,692 Added 8.79%	69,425 Common Stock
Dec 22 2020	SELL Other acquisition or disposition	-	100,000 Reduced 52.74%	89,618 Common Stock

Also insider at

KURA

Kura Oncology, Inc. Healthcare

President and CEO

PBYI

PUMA BIOTECHNOLOGY, INC. Healthcare

Director

TEW